Clinical trial
Stem Cells for Treating Critical Ischemia
NCT00488020 · Instituto de Molestias Cardiovasculares, Other · Unknown status
Key facts
| NCT number | NCT00488020 |
|---|---|
| Title | Stem Cells for Treating Critical Ischemia |
| Official title | the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia |
| Lead sponsor | Instituto de Molestias Cardiovasculares, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Critical Limb Ischemia, Ischemic Ulcers |
| Intervention type | Procedure |
| Interventions | stem cells transplant |
| Enrollment | 10 |
| Start date | Apr 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jun 19, 2007 |
| Last update posted | Jun 13, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: